IL6 and breast cancer: Skolekova et al. demonstrated that senescent hMSCs, secreting high amount of IL6 and IL8, were able to increase the resistance of breast cancer cells to cisplatin, favoured the appearance of cancer stem-like cells in vitro, and increased cisplatin resistance and tumour volume in vivo [52].